AP
Abraham Philipose Puthen Bunglowil
About Abraham Philipose Puthen Bunglowil
Data last updated:
Abraham Philipose Puthen Bunglowil is a Director at Dr.K.M.Cherian Institute Of Medical Sciences Private Limited (since 2017). The company operates in Healthcare. Dr.K.M.Cherian Institute Of Medical Sciences Private Limited reported revenue of ₹169 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dr.K.M.Cherian Institute Of Medical Sciences Private Limited U74999KL2015PTC037795 | Director | 05 May 2017 | 2015 | ₹169 Cr (FY 2025) | Active |
Board colleagues of Abraham Philipose Puthen Bunglowil
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abraham Philipose Puthen Bunglowil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abraham Philipose Puthen Bunglowil
Abraham Philipose Puthen Bunglowil currently holds 1 directorship: Dr.K.M.Cherian Institute Of Medical Sciences Private Limited (Director, since 05 May 2017, revenue ₹169 Cr (FY 2025)).
Abraham Philipose Puthen Bunglowil was first appointed on 05 May 2017 as Director at Dr.K.M.Cherian Institute Of Medical Sciences Private Limited.
The current boards of Abraham Philipose Puthen Bunglowil's companies include Akshaya Prasad (Dr.K.M.Cherian Institute Of Medical Sciences Private Limited), Amritha Suresh Pavakkulath (Dr.K.M.Cherian Institute Of Medical Sciences Private Limited), Jithin Nellickomathu Kumar (Dr.K.M.Cherian Institute Of Medical Sciences Private Limited), Jithu Tony (Dr.K.M.Cherian Institute Of Medical Sciences Private Limited), Joseph Noorokary Chacko (Dr.K.M.Cherian Institute Of Medical Sciences Private Limited), Juby Mulamoottil Mathew (Dr.K.M.Cherian Institute Of Medical Sciences Private Limited), among others.